Registry-listed formulations

This catalogue entry has no confirmed scientific concept.

Each study is counted once in the molecule profile. Registry products remain separate. Naming an ingredient does not establish that products are interchangeable or what participants received.

1 source entries across 1 studies. This list may not include all unresolved or historical entries.

  • Allogeneic hematopoietic stem cell transplant following thiotepa-based marrow ablative chemotherapyRegistry intervention

    Linked study entry; product equivalence not established

    View study and source

Success Metrics

Completion Rate
0%(0/1)
Active Trials
0(0%)
Terminated
1(100%)

Phase Distribution

Early Phase 1
1
100%

Phase Distribution

1

Early Stage

0

Mid Stage

0

Late Stage

Phase Distribution1 total trials
Early Phase 1First-in-human
1(100.0%)

Highest Phase Reached

Early Phase 1

Trial Status & Enrollment

Completion Rate

0.0%

0 of 1 finished

Non-Completion Rate

100.0%

1 ended early

Currently Active

0

trials recruiting

Total Trials

1

all time

Status Distribution
Terminated(1)

Detailed Status

Terminated1

Development Timeline

Analytics

Development Status

Total Trials
1
Active
0
Success Rate
0.0%
Most Advanced
Early Phase 1

Trials by Phase

Early Phase 11 (100.0%)

Trials by Status

terminated1100%

Recent Activity

0 active trials
Showing 1 of 1
terminatedearly_phase_1

A Multi-Institutional Pilot Study of Allogeneic Hematopoietic Stem Cell Transplantation for Patients With Malignant Neuro-Epithelial and Other Solid Tumors

NCT02653196

Clinical Trials (1)

Showing 1 of 1 trials
NCT02653196Early Phase 1

A Multi-Institutional Pilot Study of Allogeneic Hematopoietic Stem Cell Transplantation for Patients With Malignant Neuro-Epithelial and Other Solid Tumors

Terminated

All 1 trials loaded

Drug Details

Intervention Type
Procedure
Total Trials
1